Skip to main content

Advertisement

Table 14 Association between sponsor and conclusion on reported outcome: Tolerance symptoms

From: Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: A Systematic Review

Tolerance Source of funding No conclusion on reported outcome Positive Negative Chi-square p value Fisher’s exact p value
n (%)$$ n (%)$$ n (%)$$
Colic N = 13 Industry 10 (76.9) 2 (15.4)   0.657 1.00
  None/Not clear      
  Non industry 1 (7.7)     
Spitting up/Regurgitation N = 26 Industry 19 (73.1) 1 (3.8)   0.032 0.062
  None/Not clear 2 (7.7) 2 (7.7)    
  Non industry 2 (7.7)     
Vomiting N = 32 Industry 19 (59.4) 5 (15.6)    
  None/Not clear 3 (9.4) 3 (9.4)    
  Non industry 2 (6.3)     
Crying Fussiness N =20 Industry 10 (50) 6 (30)   0.648 1.00
  None/Not clear 2 (10) 2 (10)    
  Non industry 0     
Gastric residuals, Abdominal distension N = 6 Industry   1 (16.7)   0.513 1.00
  None/Not clear 1 (16.7) 1 (16.7)    
  Non industry 2 (33.3) 1 (16.7)    
Volume of formula consumed/daily intake N = 30 Industry 19 (63.3) 2 (6.7) 1 (3.3) 0.867 0.733
  None/Not clear 3 (10.0)     
  Non industry 4 (13.3) 1 (3.3)    
Days to full enteral feeding N = 8 Industry 2 (25)   1 (12.5) 0.547 1.00
  None/Not clear 1 (12.5) 1 (12.5)    
  Non industry 2 ()25 1 (12.5)    
  1. $$Overall percentage.